Skip to content

Clinical trials

Observational Carcinoma, Hepatocellular trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Observational Country / region: United States Clear all

118 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20023
20033
20043
20073
20087
20098
20103
20115
20121
20133
20146
20159
20165
20175
20187
20198
20204
20217
20228
20233
20249
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed56
Recruiting22
Terminated14
Active, not recruiting8
Unknown status8
Withdrawn5
Enrolling by invitation2
Not yet recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic6
National Cancer Institute (NCI)5
Stanford University5
City of Hope Medical Center4
Northwestern University4
Bayer3
Boston Scientific Corporation2
Eisai Inc.2
Exact Sciences Corporation2
M.D. Anderson Cancer Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular118
Liver Neoplasms40
Cholangiocarcinoma13
Pancreatic Neoplasms13
Carcinoma, Renal Cell11
Colonic Neoplasms11
Neoplasms11
Colorectal Neoplasms10
Stomach Neoplasms10
Carcinoma, Non-Small-Cell Lung9

Trials

Showing 1 to 25 of 118. Each trial links to its page on Pharma Observatory.

18 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.